| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $9.2M | -23.1% |
| SG&A Expense | $18.5M | +1.6% |
| Operating Income | -$38.5M | +8.3% |
| Interest Expense | $50K | — |
| Pre-tax Income | -$38.7M | +0.4% |
| Income Tax | $1.1M | +83.5% |
| Net Income | -$39.7M | -0.8% |
| EPS (Basic) | -$3.38 | +43.4% |
| EPS (Diluted) | -$3.38 |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.3M | +30.8% |
| Inventory | $22.3M | +169.5% |
| Current Assets | $27.9M | +96.4% |
| Total Assets | $130.9M | +12.2% |
| Current Liabilities | $44.9M | +25.4% |
| Total Liabilities | $53.4M | +25.5% |
| Stockholders' Equity | $67.6M | -3.6% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$26.6M | +5.8% |
| Investing Cash Flow | -$5.8M | -15.0% |
| Financing Cash Flow | $33.3M | +234.0% |
| +43.4% |